The Probe That Changed Everything
In the summer of 1972, inside a factory in Gloucestershire that existed to machine jet engine components for Rolls-Royce, a metrologist named David McMurtry confronted a problem that would have defeated most engineers by its sheer banality. The Olympus engines destined for the Concorde supersonic airliner required fuel pipes machined to tolerances so tight — fractions of a thousandth of an inch — that the existing method of measurement, which involved manually positioning a rigid stylus against a workpiece and reading a dial, could not keep pace with production. The pipes were three-dimensional curves. The measurement points numbered in the hundreds. Every manual touch introduced operator error, and every error cascaded into scrap, rework, and delay on a programme already drowning in both.
McMurtry's solution was so elegant it barely looked like an invention: a spring-loaded probe tip, mounted on a coordinate measuring machine, that deflected on contact and triggered an electronic signal at a repeatable force. The touch-trigger probe. It didn't measure anything itself — it simply told the machine when it had arrived at a surface, with sub-micron consistency, thousands of times an hour, without fatigue or ego. The probe converted measurement from craft into automation, from human judgment into digital coordinates. It was, in retrospect, less a product than a protocol — the foundational grammar of precision manufacturing for the next half-century.
From that single invention, McMurtry and his co-founder John Deer built Renishaw into a company that, as of fiscal year 2024, generated £688.6 million in revenue, employed more than 5,000 people across 36 countries, and commanded market positions in precision metrology, additive manufacturing, spectroscopy, neurological surgery, and position encoding that share almost nothing in common except an obsessive, occasionally stubborn devotion to measurement at the limits of physical possibility. Renishaw is not a household name. It is something more durable: the invisible infrastructure of accuracy, embedded in every semiconductor fab, every aerospace machine shop, every dental laboratory, and an increasing number of operating theatres where surgeons navigate the human brain by coordinate geometry.
The company's story is not a Silicon Valley parable of disruption and pivot. It is a distinctly British — and distinctly idiosyncratic — narrative about what happens when two engineers refuse to sell, refuse to be acquired, refuse to chase quarterly consensus, and instead compound a technological advantage for five decades while retaining majority ownership and reinvesting at rates that would make most public-company boards revolt. It is also, now, a succession story with genuine stakes: McMurtry, born in 1940, and Deer, born in 1942, together controlled approximately 53% of Renishaw's shares as recently as 2022. The question of what Renishaw becomes after its founders is not abstract. It is the question.
By the Numbers
Renishaw at a Glance (FY2024)
£688.6MRevenue (year ending June 2024)
£130.5MAdjusted operating profit
19.0%Adjusted operating margin
£5.1BApproximate market capitalisation
5,265Employees worldwide
95%Revenue generated outside the UK
~4,800Active patents and patent applications
13–18%Typical R&D spend as percentage of revenue
Two Engineers and a Garage — But Not That Kind of Garage Story
David McMurtry grew up in Clonmel, County Tipperary, studied mechanical engineering, and joined Rolls-Royce's aero engine division in Bristol, where he rose to become deputy chief designer. He was — and remains, well into his eighties — an engineer of preternatural spatial intuition, the kind of person who sees a coordinate system where others see a surface. John Deer, a quieter figure, had a complementary gift for systems, production, and the patient mechanics of turning a prototype into a product that ships.
The founding mythology is tidy: McMurtry invented the touch-trigger probe in 1972 to solve the Concorde inspection problem, Rolls-Royce licensed it, and by 1973, McMurtry and Deer had formed Renishaw Electrical Ltd. — named after the hamlet of Renishaw in Derbyshire, near one of Deer's family connections — to manufacture and sell the probe commercially. The company operated out of McMurtry's garage, then a rented facility in Wotton-under-Edge, a market town in the Cotswolds that remains Renishaw's global headquarters to this day.
What makes the origin story less tidy, and more instructive, is the patent fight. McMurtry's invention was so fundamental — so obviously the right way to automate dimensional inspection — that competitors immediately attempted to design around or challenge the patents. Renishaw spent much of its first two decades in intellectual property litigation that consumed management attention, legal fees, and emotional energy on a scale that would have forced most small companies to settle or sell. They did neither. McMurtry and Deer defended their patents with a ferocity that established two principles that would define Renishaw for the next fifty years: first, that intellectual property is the company's primary asset, more valuable than any factory or customer relationship; and second, that Renishaw would rather litigate than license, rather fight than accommodate, rather be right than be popular.
The patent battles — particularly against competitors in the United States and Germany — also taught McMurtry something subtler. A single invention, no matter how foundational, is a wasting asset. Patents expire. Competitors learn. The only durable defence is continuous invention — not incremental improvement, but genuine leaps that reset the competitive clock. This insight became the engine of Renishaw's capital allocation: reinvest relentlessly in R&D, at rates typically between 13% and 18% of revenue, year after year, through cycles, through downturns, through periods when the market begged for higher dividends or share buybacks. The R&D intensity is not a strategy bolted on to a manufacturing business. It is the business.
The Geometry of Competitive Advantage
To understand why Renishaw's core metrology business prints the margins it does — adjusted operating margins consistently in the high teens to mid-twenties over multi-year cycles — you need to understand the peculiar economics of precision measurement in manufacturing.
A coordinate measuring machine (CMM), the workhorse of quality inspection in aerospace, automotive, and electronics manufacturing, might cost £100,000 to £2,000,000. The probes, styli, and software that make it useful — overwhelmingly supplied by Renishaw — represent a fraction of that capital cost but are the components that determine accuracy, speed, and repeatability. More critically, once a factory has calibrated its inspection routines around Renishaw's probing system, switching to a competitor's system involves not just hardware replacement but recalibration, revalidation, and requalification of every measurement routine — a process that in regulated industries like aerospace or medical devices can take months and cost multiples of the hardware savings.
This is the classic installed-base economics of a high-switching-cost consumable, and Renishaw exploits it with the quiet efficiency of a razor-and-blade model, except that the blades are styli tips made of ruby and tungsten carbide and the razors are CMMs made by other companies. Renishaw's probe heads are the de facto standard on CMMs manufactured by Hexagon, Zeiss, Mitutoyo, and others. The probe is the interface between the machine and the workpiece, and Renishaw owns that interface.
But the razor-and-blade analogy understates the depth of the moat. Renishaw is not merely selling replacement tips. It is selling an ecosystem of probing hardware, software, and calibration artifacts that together define the language of measurement in a factory. Its REVO five-axis measurement system, introduced in the 2000s, can measure complex surfaces at scanning speeds that reduce inspection time by as much as 75% compared to conventional touch-trigger methods — but it requires Renishaw's controller, Renishaw's software, and Renishaw's probe heads. The system is open enough to work with third-party CMMs but closed enough that the intelligence — the firmware, the error compensation algorithms, the calibration routines — lives inside Renishaw's stack.
We have never been interested in being a commodity supplier. If you are in a commodity market, you are in a price war, and in a price war, the biggest company wins. We prefer to be in a technology war, because in a technology war, the best company wins.
The on-machine probing business extends this logic from the inspection room to the shop floor. Renishaw's machine tool probes — mounted directly on CNC milling machines, lathes, and grinders — allow the machine to measure the workpiece during the cutting process, compensating in real time for tool wear, thermal drift, and fixture errors. This is not post-process inspection; it is closed-loop manufacturing, and it converts what was historically a quality control cost centre into a productivity tool. The value proposition to a machine shop is not "measure more accurately" but "make fewer bad parts" — which translates directly into reduced scrap, shorter cycle times, and lower cost per part.
The installed base of Renishaw machine tool probes is enormous. The company has shipped millions of probes into CNC machines worldwide, and the replacement cycle — styli wear out, probe batteries expire, software updates unlock new capabilities — generates a recurring revenue stream that smooths the cyclicality inherent in capital equipment sales. Renishaw does not disclose the precise split between initial probe sales and aftermarket revenue, but the company's historical resilience in down-cycles — revenue fell 19% in the 2009 recession but operating profit remained positive — suggests a substantial recurring base.
The Encoder Kingdom
If Renishaw's metrology business is the heart, position encoders are the nervous system — less visible, less discussed in the financial press, but arguably the more strategically important business over the next two decades.
An encoder converts physical position into a digital signal. Every time a semiconductor lithography machine aligns a wafer, every time an industrial robot returns to a taught position, every time a telescope mirror adjusts for atmospheric distortion, an encoder is reporting position with nanometre-level precision. Renishaw's optical and magnetic encoders are embedded inside the motion systems of ASML, FANUC, Siemens, and dozens of other OEMs whose names appear on the machine but whose accuracy depends on a Renishaw scale and read head buried inside.
The encoder business illustrates Renishaw's characteristic approach to market entry: identify a measurement problem at the frontier of precision, develop a proprietary solution, and embed it so deeply in the customer's design that extraction becomes unthinkable. Renishaw's RESOLUTE absolute encoder, launched in 2010, achieves resolution to one nanometre — one billionth of a metre — at speeds up to 100 metres per second. The physics required to achieve this (interferometric-scale optical gratings, signal processing algorithms that compensate for contamination and vibration) represent decades of accumulated know-how that cannot be replicated by reading a patent.
The encoder business is also less cyclical than metrology, because encoder demand is driven by the long-term growth of automation, semiconductor capital expenditure, and precision motion systems — all of which are structurally growing faster than
GDP. When ASML ships more EUV lithography machines, Renishaw ships more encoders. When FANUC sells more robots, Renishaw sells more encoders. The encoder is the tax on precision motion, and precision motion is the direction of industrial civilisation.
The Additive Bet
In 2011, Renishaw acquired the additive manufacturing business of MTT Technologies, a UK-based maker of metal powder bed fusion systems. It was, at the time, a puzzling move. Renishaw was a measurement company; additive manufacturing — then still widely called "3D printing" and associated more with plastic prototyping than serious production — was a fabrication technology. The adjacency was non-obvious. McMurtry saw something others didn't, or saw it earlier: that metal additive manufacturing would become a production technology for aerospace, medical, and dental applications, and that the critical bottleneck would be
process control — the ability to measure, monitor, and guarantee the quality of parts built layer by layer from metal powder.
Measurement, in other words. Renishaw's core competence.
The bet was expensive. For more than a decade, the additive manufacturing division consumed capital, reported losses or minimal profits, and tested the patience of investors who wanted the R&D spend redirected to the high-margin metrology business. Renishaw invested heavily in its RenAM 500 series of metal laser melting systems, in process monitoring technologies (InfiniAM), and in application engineering for dental frameworks, orthopaedic implants, and aerospace brackets.
By 2023, the additive manufacturing business had reached an inflection point. Dental applications — specifically the production of cobalt-chrome frameworks for dental prosthetics — proved to be the beachhead. The value proposition was compelling: a dental laboratory could replace labour-intensive lost-wax casting with a digital workflow (scan, design, print, finish) that was faster, more consistent, and more economical at scale. Renishaw's dental business grew rapidly as digital dentistry adoption accelerated, particularly in China and Europe.
The strategic logic, viewed with hindsight, is characteristic McMurtry: enter a nascent market early, absorb years of losses while developing proprietary process know-how, and emerge on the other side with an integrated hardware-software-process solution that competitors — who entered late and lack the metrology DNA — cannot easily replicate. Whether additive manufacturing becomes a significant profit contributor remains debated. The division is growing but remains a small fraction of group revenue. The bulls argue it's a $10 billion addressable market in which Renishaw has a differentiated position. The bears argue Renishaw is a £700 million company competing against EOS, GE Additive (now part of Colibrium), and SLM Solutions (acquired by Nikon) in a market that rewards scale. Both are right.
Neurological Detours and Other Obsessions
There is a wing of Renishaw's portfolio that defies conventional portfolio logic: neurological surgery robotics. Renishaw's neuromate and neuroinspire systems are used in stereotactic neurosurgery — the placement of electrodes, biopsies, and drug delivery devices deep inside the brain using coordinate-guided robotics. The systems are cleared by the FDA and CE-marked, and they are used in procedures including deep brain stimulation for Parkinson's disease, stereoelectroencephalography for epilepsy diagnosis, and experimental drug delivery for brain tumours.
The neurosurgery business is tiny relative to the group — Renishaw does not break out its revenue separately, but it is almost certainly in the low tens of millions of pounds. It is also, by any financial metric, a questionable capital allocation. The regulatory burden is immense. The addressable market is small. The sales cycles are glacial. And yet McMurtry has funded it for over two decades, because the problem — navigating three-dimensional space inside the human skull with sub-millimetre accuracy — is, at its core, a metrology problem, and he finds it irresistible.
This is the tension at the heart of Renishaw's strategy, and it would be dishonest to resolve it cleanly. The same R&D obsession that produced the REVO five-axis system and the RESOLUTE encoder also produced a neurological surgery robot that may never generate returns commensurate with the invested capital. The company's Raman spectroscopy instruments — used in pharmaceutical analysis, materials science, and forensics — occupy a similarly ambiguous position: technically impressive, strategically interesting, financially marginal. Renishaw's willingness to pursue these adventures is simultaneously its greatest cultural strength (it attracts engineers who want to solve hard problems, not optimise ad click-through rates) and its most persistent governance question (who decides when to kill a project that the 84-year-old founder finds fascinating?).
We have always taken the view that you have to invest in the technology first and the market will follow. If you wait for the market to tell you what it wants, you are already too late.
The Succession Question
In July 2021, Renishaw announced that it had explored a potential sale of the company and decided not to proceed. The announcement landed like a controlled detonation in the precision engineering world. McMurtry and Deer, then 81 and 79 respectively, had hired Lazard to run a formal process, received expressions of interest from private equity firms and strategic buyers, and ultimately concluded that none of the offers met their criteria for a buyer who would preserve the company's culture, commitment to R&D investment, UK manufacturing base, and long-term independence.
The episode revealed several things simultaneously. First, that the founders were actively thinking about succession and estate planning — their combined 53% stake, at prevailing market prices, was worth roughly £3.5 billion, creating estate tax liabilities of staggering proportions. Second, that the private equity industry's appetite for high-quality UK industrial companies was ravenous. Third, and most importantly, that McMurtry and Deer ultimately could not bring themselves to hand the company to buyers whose incentive structures — levered returns over five-to-seven-year hold periods — were antithetical to everything they had built.
The decision not to sell was widely praised by employees and customers, and widely questioned by minority shareholders who had seen the share price spike 30% on sale rumours and wanted liquidity. Since then, the succession plan has taken a different shape. Will Lee, a career Renishaw engineer who joined the company in 2001, was appointed Chief Executive in 2018 and has gradually assumed operational control. McMurtry and Deer have reduced their combined shareholding incrementally — by early 2024, McMurtry held approximately 36% and Deer approximately 17%, suggesting ongoing estate planning through structured disposals.
The question that hangs over Renishaw is not whether Lee is competent — by all available evidence, he is a capable operator who understands the product portfolio and the customer base intimately. The question is whether Renishaw's distinctive culture — the willingness to invest for decades without near-term returns, the tolerance for quixotic R&D bets, the refusal to be managed to quarterly earnings — can survive the transition from founder control to institutional ownership. McMurtry's shareholding is a governance moat: as long as he holds a blocking stake, no activist, no acquirer, and no impatient board can force Renishaw to behave like a normal public company. When that stake eventually disperses — through death, estate transfers, or charitable disposition — the governance structure becomes conventional, and conventional governance tends to optimise for conventional returns.
Manufacturing as Ideology
Renishaw manufactures almost everything in-house, in the UK, and this is not merely an operational choice but an ideological commitment that shapes the company's cost structure, product architecture, and competitive position in ways both advantageous and constraining.
The company's primary facilities are in Wotton-under-Edge, Woodchester, and Miskin (South Wales), with additional manufacturing in Pune, India, and Dublin, Ireland. The Miskin plant, a 60,000-square-metre facility opened in 2019, represented a £67 million investment and was the largest single capital project in Renishaw's history. The plant produces encoders, probe heads, and other precision components using Renishaw's own CNC machines, calibrated by Renishaw's own probes, inspected by Renishaw's own measurement systems. The recursion is not accidental — Renishaw is its own most demanding customer, and the production process serves as a continuous real-world test of its own products.
The vertical integration extends to components that most companies would outsource: custom ASICs for signal processing, optical gratings for encoders, ruby styli for probes, even the machine tools used in production. The logic is Renishaw's version of
Steve Jobs's "own the whole widget" philosophy, adapted for precision manufacturing: if you control every stage of production, you control every source of error, and in a business where competitive advantage is measured in nanometres, controlling error
is competitive advantage.
The cost is structural. Renishaw's manufacturing base is predominantly UK-based, in a country with high energy costs, high labour costs relative to Asia, and a currency (sterling) that, when strong, makes exports less competitive. The company employs over 3,000 people in the UK, including a large cohort of skilled machinists, assemblers, and technicians whose expertise is difficult to replicate but whose cost structure is difficult to justify on a pure unit-economics basis against Asian competitors. Renishaw partially mitigates currency exposure through natural hedging (some costs are in non-sterling currencies) and through the premium pricing that its brand and technology command, but the fundamental tension between UK manufacturing and global price competition is a recurring theme in analyst calls.
We make what we sell and we sell what we make. That vertical integration gives us control over quality, over supply chain, and critically over the rate of innovation. We don't wait for a supplier to develop the next generation of a component — we develop it ourselves.
Cycles, Semiconductors, and the Revenue Roller Coaster
Renishaw's revenue profile is cyclical in a way that no amount of recurring aftermarket revenue fully smooths. The company sells capital equipment — probes, encoders, additive manufacturing systems, spectroscopy instruments — to manufacturers whose purchasing decisions are tied to industrial capex cycles, semiconductor investment cycles, and automotive production cycles. When TSMC and Samsung accelerate fab construction, Renishaw's encoder business surges. When automotive OEMs cut capacity, machine tool probe orders fall. When aerospace MRO spending rises, CMM probe demand follows.
The cyclicality has been dramatic. In fiscal year 2022, revenue reached £671.1 million — a record at the time — driven by post-pandemic semiconductor capex and industrial restocking. In fiscal 2023, revenue declined to £688.6 million after a brief dip (the timing of Renishaw's June fiscal year-end makes year-on-year comparisons tricky), but the path was uneven: the first half was strong, the second half weakened as semiconductor and consumer electronics demand softened. The share price, which peaked near £67 in early 2022, fell below £35 by late 2023 as investors extrapolated the downturn.
What makes Renishaw's cyclicality distinctive — and, for patient investors, potentially attractive — is the company's behaviour during downturns. Unlike most cyclical industrials, which cut R&D, freeze hiring, and hoard cash when revenue falls, Renishaw maintains or increases R&D spending through cycles, on the theory that downturns are precisely when competitors cut investment and when the best engineering talent becomes available. This counter-cyclical R&D investment is funded by a balance sheet that carries minimal debt — net cash of £87 million at June 2024 — and by founders whose 53% ownership stake immunises them from short-term earnings pressure.
The result, viewed over decades, is a company that emerges from each downturn with a wider product portfolio, a deeper technology moat, and a larger share of a growing market. The cost is earnings volatility that looks ugly in any given year but compounds into something remarkable over twenty-year periods.
Renishaw revenue and operating margin through recent cycles
| Fiscal Year | Revenue (£M) | Adj. Operating Margin | Context |
|---|
| FY2019 | 574.0 | 17.8% | Trade war slowdown |
| FY2020 | 510.2 | 10.4% | COVID shock |
| FY2021 | 565.6 | 18.3% | Post-COVID recovery |
| FY2022 | 671.1 | 22.6% | Semiconductor capex boom |
|
The Geography of Precision
Ninety-five percent of Renishaw's revenue is generated outside the United Kingdom. The APAC region — led by China, Japan, South Korea, and Taiwan — accounts for approximately 45–50% of group revenue. The Americas represent roughly 20%, and Continental Europe another 25%. The UK itself, despite hosting the company's entire manufacturing and R&D infrastructure, generates only about 5% of sales.
This geographic profile embeds a strategic concentration risk that Renishaw's management discusses with notable candour. China alone can represent 15–20% of group revenue in strong years, and the combination of Chinese industrial policy (which favours domestic suppliers), geopolitical tension (which could restrict technology exports), and cyclicality (Chinese manufacturing PMI swings drive probe and encoder demand) creates a vulnerability that no amount of diversification within China can eliminate.
Japan is a different kind of exposure — less politically volatile but structurally tied to the health of Japan's machine tool industry, which is itself a bellwether for global manufacturing capex. When Japanese machine tool orders (tracked monthly by the Japan Machine Tool Builders' Association) rise, Renishaw's Japanese revenue rises; when they fall, Renishaw feels it within a quarter.
The semiconductor supply chain concentration is particularly acute. Renishaw's encoder business benefits enormously from the capex cycles of TSMC, Samsung, Intel, and the handful of lithography, deposition, and etch equipment makers (ASML, Applied Materials, Lam Research, Tokyo Electron) that serve them. This exposure is a double-edged sword: the secular tailwinds of semiconductor investment — AI, electrification, IoT — are powerful, but the cyclicality is savage. The 2023–2024 semiconductor inventory correction hit Renishaw's encoder order book hard, and the recovery will depend on factors entirely outside the company's control.
A Cathedral Built in Microns
Wotton-under-Edge is not where you expect to find the headquarters of a company with a £5 billion market capitalisation. The town has roughly 6,000 residents, a weekly market, and a medieval parish church. Renishaw's campus on the edge of town — a growing complex of engineering buildings, clean rooms, and assembly halls — is, by some margin, the town's largest employer and most improbable institution.
There is something irreducibly McMurtry about this. The refusal to relocate to London, or Reading, or Cambridge — places where an ambitious technology company might logically establish itself for access to capital markets, universities, and talent — is a statement about what Renishaw values. The company recruits heavily from local schools and universities, runs extensive apprenticeship programmes (over 50 apprentices at any given time), and has invested in STEM education initiatives across South West England and South Wales with a persistence that suggests genuine conviction rather than corporate social responsibility window dressing.
The campus itself embodies the Renishaw paradox: world-class technology developed and manufactured in pastoral English settings that could be the backdrop for a BBC period drama. CNC machines cutting encoder scales to nanometre tolerances, a few hundred metres from fields where sheep graze. It is a reminder that advanced manufacturing does not require a Silicon Valley postcode — it requires decades of accumulated know-how, a culture that respects craft, and founders who have the patience (and the equity stake) to let compounding do its work.
McMurtry, who was knighted in 2001 for services to design and innovation, still came into the office regularly well into his eighties. Deer, more private, stepped back from daily operations earlier but remained on the board. Together they built not just a company but an institution — one whose peculiar combination of technological excellence, geographic stubbornness, financial conservatism, and founder eccentricity has no real analogue in British industry. The closest comparison might be Danaher in the United States, but Danaher is a conglomerate of acquired businesses managed by process; Renishaw is an organism that grew from a single cell, by mitosis, for fifty years.
The touch-trigger probe that McMurtry invented in 1972 to solve a manufacturing problem on Concorde is still sold, in evolved form, as part of Renishaw's product line. The original patent expired decades ago. It didn't matter. By the time competitors could legally copy the probe, Renishaw had moved to scanning probes, five-axis probes, optical encoders, Raman spectrometers, and metal additive manufacturing systems — each new product building on the measurement expertise embedded in the one before, each new layer of the stack making the whole more difficult to replicate. Fifty-two years later, in a factory in Gloucestershire, spring-loaded probe tips still click against metal surfaces, a few microns at a time, counting the shape of the world.
Renishaw's half-century trajectory encodes a set of operating principles that are neither intuitive nor easily replicated — they arise from the specific conditions of founder control, technological obsession, and patience with capital that few public companies can sustain. What follows is an attempt to make them explicit, not as platitudes but as strategic choices with real costs.
Table of Contents
- 1.Own the interface, not the machine.
- 2.Outspend the cycle.
- 3.Litigate like your life depends on it — because it does.
- 4.Vertical integration as error control.
- 5.Enter early, lose money, learn process.
- 6.Make geography a filter, not a constraint.
- 7.Let the founders be weird.
- 8.Build the installed base; harvest the aftermarket.
- 9.Treat the balance sheet as a weapon, not a scorecard.
- 10.Plan succession as if the company's culture is the asset.
Principle 1
Own the interface, not the machine.
Renishaw's most consequential strategic insight was recognising that the value in precision manufacturing does not reside in the machine tool or the coordinate measuring machine — both of which are large, complex, and made by competitors — but in the interface between the machine and the physical world. The probe tip that touches the workpiece. The encoder scale that reports position. The calibration artifact that defines truth. These are the components that determine the accuracy of everything downstream, and they are the components with the highest switching costs, the deepest embeddedness, and the most favourable unit economics.
By focusing on the interface, Renishaw avoided the brutally competitive machine tool industry — where Mazak, DMG Mori, and Okuma slug it out on price — and instead became the universal supplier of accuracy to all of them. Renishaw's probes are mounted on competitors' machines. Its encoders are inside competitors' robots. The company is the Switzerland of precision: neutral, essential, and extremely profitable.
How Renishaw embeds at the measurement layer
| Interface Layer | Renishaw Product | OEM Customer | Switching Cost |
|---|
| CMM inspection | PH20, REVO probe heads | Hexagon, Zeiss, Mitutoyo | Very high (recalibration) |
| CNC machine tool | OMP, RMP probes | Mazak, DMG Mori, Okuma | High (integration, training) |
| Semiconductor equipment | RESOLUTE, TONiC encoders | ASML, Applied Materials | Extremely high (design-in) |
| Robotics / motion | Magnetic, optical encoders | FANUC, ABB, Siemens |
Benefit: Interface ownership delivers recurring revenue, premium pricing, and competitive insulation. Renishaw can grow without competing directly with its customers.
Tradeoff: Dependency on OEM relationships means Renishaw has limited control over end-market demand. If Hexagon decides to develop its own probe system (as it has occasionally attempted), Renishaw faces a channel threat. The interface is powerful precisely because it is small — but smallness also means Renishaw's revenue is a rounding error in most OEMs' COGS, which cuts both ways.
Tactic for operators: Map your market's value chain and find the layer where switching costs are highest relative to the dollar value of the component. That's your interface. Own it, and let others build the commodity hardware around you.
Principle 2
Outspend the cycle.
Most industrial companies cut R&D during downturns. It is rational, legible to investors, and strategically suicidal over twenty-year periods. Renishaw does the opposite: R&D spending as a percentage of revenue actually rises during downturns, because the numerator stays flat or increases while the denominator shrinks. In FY2020, when COVID cut revenue by 11%, Renishaw's R&D spend as a percentage of revenue exceeded 15%. In FY2022, when revenue surged, the percentage fell to around 13% — not because absolute spending declined but because revenue outpaced it.
The logic is McMurtry's, and it is deeply felt: downturns are when competitors retrench, when the best engineers are easiest to recruit, and when the seeds of the next product cycle should be planted. The touch-trigger probe was invented during the economic turbulence of the early 1970s. The REVO system was developed through the 2000s recession. The additive manufacturing business was built during a decade of uncertain demand.
Counter-cyclical R&D investment requires two preconditions: a fortress balance sheet (Renishaw carries net cash and minimal debt) and a governance structure that insulates management from short-term earnings pressure (53% founder ownership). Without both, the principle is aspirational rather than operational.
Benefit: Renishaw enters each upcycle with a wider, more advanced product portfolio than competitors who cut R&D. The compounding effect over multiple cycles is enormous — the company's 4,800+ patents are the cumulative output of five decades of consistent investment.
Tradeoff: Earnings volatility is brutal. Investors who compare Renishaw's margins against asset-light software companies or US industrial peers with more variable cost structures will always find it wanting in down-cycles. The stock trades at a perpetual "cyclical discount" that the counter-cyclical R&D spend deserves credit for but rarely receives.
Tactic for operators: If you have the balance sheet to sustain it, increase R&D hiring during downturns. Talent is available, competitors are distracted, and the products you build today will ship into the next upcycle. But only do this if you genuinely have 18–24 months of runway without revenue improvement — otherwise it's not counter-cyclical investing, it's just burning cash.
Principle 3
Litigate like your life depends on it — because it does.
Renishaw's first two decades were defined as much by courtrooms as by engineering labs. The company prosecuted and defended patent infringement cases across the United States, Germany, Japan, and the UK, spending sums that — for a small company — were genuinely threatening. The returns on that investment were existential: by establishing that competitors could not freely copy the touch-trigger probe, Renishaw created a window of exclusivity that funded the next generation of products, which generated the next set of patents, which funded the next round of litigation.
The lesson is not "spend heavily on lawyers." It is that for technology-driven businesses operating in markets where the marginal cost of copying a design is far lower than the cost of inventing it, aggressive IP defence is not a luxury — it is the mechanism by which R&D investment generates returns. Without enforcement, patents are decorative.
Benefit: Decades of aggressive IP enforcement established Renishaw's reputation as a company you do not copy. This deterrent effect — the expectation of litigation — is now arguably more valuable than any individual patent.
Tradeoff: IP litigation is expensive, unpredictable, and creates adversarial relationships. Renishaw's combative posture on IP has, at times, strained relationships with potential partners and created a cultural insularity that can shade into arrogance.
Tactic for operators: If your competitive advantage is proprietary technology, budget for IP enforcement from day one — not as a legal cost but as an R&D multiplier. A patent you won't enforce is a patent you wasted money filing.
Principle 4
Vertical integration as error control.
Renishaw's decision to manufacture almost everything in-house — from ASICs to optical gratings to ruby styli — is not primarily about cost (it is more expensive than outsourcing) or about supply chain security (though that is a benefit). It is about error control. In a business where the product's value proposition is measured in nanometres, every outsourced component is a source of variability that Renishaw cannot control. By manufacturing internally, the company controls every tolerance, every material specification, every process parameter that contributes to the final product's accuracy.
The Miskin plant in South Wales, opened in 2019, exemplifies this philosophy. It produces encoder components in clean-room conditions using Renishaw's own photolithography processes, calibrated by Renishaw's own metrology systems. The feedback loop — product quality informs process improvement, which informs product development — is impossible to replicate with outsourced manufacturing.
Benefit: Renishaw's products are measurably more accurate and more reliable than competitors', which sustains premium pricing. The vertical integration also creates a formidable barrier to entry — a new competitor would need to replicate not just the product design but the entire manufacturing process chain.
Tradeoff: The cost structure is permanently higher than competitors who outsource to Asia. Gross margins, while healthy (typically 50–55%), are lower than they would be with a leaner manufacturing model. The UK manufacturing base also creates currency exposure and geographic concentration risk.
Tactic for operators: Integrate vertically only in the dimensions that directly determine your product's core value proposition. For Renishaw, that's accuracy. For a software company, it might be data infrastructure. For a consumer brand, it might be the customer experience layer. Everything else, outsource ruthlessly.
Principle 5
Enter early, lose money, learn process.
Renishaw's entry into additive manufacturing in 2011, and into neurological surgery robotics in the early 2000s, followed a pattern: identify a nascent market where measurement and precision are the binding constraints, enter before the market is commercially viable, invest in developing proprietary process knowledge, and tolerate years of losses while building an expertise base that later entrants cannot quickly replicate.
The additive manufacturing business lost money for over a decade before reaching meaningful scale. The neurosurgery business may never reach scale by conventional financial standards. Both represent deliberate strategic choices to trade near-term profitability for long-term optionality, underwritten by a core business (metrology) that generates sufficient cash flow to fund the experiments.
Benefit: When a nascent market inflects — as dental additive manufacturing did in 2020–2023 — Renishaw has a decade's head start in process knowledge, customer relationships, and regulatory approvals.
Tradeoff: Capital trapped in pre-profit businesses depresses group returns on invested capital and irritates investors focused on capital efficiency. Not every bet pays off — Renishaw's spectroscopy business has been a slow grower for years.
Tactic for operators: Allocate 10–15% of R&D budget to "decade bets" — technologies that won't generate returns for 7–10 years. Fund them from the core business, ring-fence the budget, and evaluate them on learning milestones rather than revenue milestones. But be honest: this only works if the core business is healthy enough to fund the experiments.
Principle 6
Make geography a filter, not a constraint.
Renishaw's decision to base its operations in Wotton-under-Edge and Miskin — not London, not Cambridge, not a global hub — is a deliberate talent filter. It selects for engineers who want to solve hard technical problems in a quiet environment, not for MBA generalists who want proximity to capital markets. The geographic choice creates a self-selecting workforce that is deeply technical, deeply loyal (turnover is low by industry standards), and deeply embedded in the local communities where Renishaw operates.
Benefit: Lower turnover, higher institutional knowledge retention, and a culture of long-tenure engineering excellence. Many of Renishaw's senior engineers have been with the company for 20+ years, accumulating knowledge that is nearly impossible to codify or transfer.
Tradeoff: Recruitment is harder for roles that require specific skills (AI/ML, advanced software engineering) that cluster in major cities. The geographic isolation can breed insularity — a tendency to prioritise engineering elegance over market needs.
Tactic for operators: If your competitive advantage is deep technical expertise, consider locating away from talent hotspots. You'll attract fewer applicants but more committed ones. This is not universally applicable — some businesses require network-dense locations — but for R&D-intensive companies, the quality-over-quantity trade can be decisive.
Principle 7
Let the founders be weird.
McMurtry's decision to invest in neurological surgery robotics, Raman spectroscopy, and a dozen other projects that a professional CEO would have killed years ago is not, strictly speaking, rational capital allocation. It is the expression of a founder's curiosity, protected by a governance structure (majority ownership) that shields it from market discipline.
And yet. The neurological surgery business has produced genuine medical innovations. The spectroscopy business serves pharmaceutical companies and forensic laboratories. The additive manufacturing business — originally a McMurtry enthusiasm project — is now a real business with real growth. Founder eccentricity, in Renishaw's case, has been a source of optionality that more disciplined capital allocation would have destroyed.
Benefit: Curiosity-driven R&D produces unexpected adjacencies and attracts world-class engineers who are drawn to hard problems.
Tradeoff: Some investments will never generate returns. The capital trapped in marginal businesses could have been returned to shareholders or invested in the core metrology business. The "let founders be weird" principle only works when the core business is extraordinarily strong.
Tactic for operators: If you are a founder with a controlling stake, ring-fence a budget (no more than 5–10% of operating cash flow) for projects that fascinate you but have no clear business case. Call it what it is — an optionality budget. If you are a board member, protect this budget from efficiency-minded managers, but insist on rigorous tracking of what's been learned, not what's been earned.
Principle 8
Build the installed base; harvest the aftermarket.
Renishaw's business model rests on a dynamic that takes decades to build: sell a precision instrument at moderate margins, embed it deeply in the customer's production process, and then generate high-margin recurring revenue from replacement styli, calibration services, software updates, and support contracts. The initial sale is the beachhead; the aftermarket is the occupation.
The installed base of Renishaw probes on CNC machines worldwide likely numbers in the millions. Each probe consumes styli (ruby tips on tungsten carbide shafts) that wear out and must be replaced. Each calibration artifact requires periodic recertification. Each software licence generates upgrade revenue. None of this is disclosed separately in Renishaw's financials, but the company's resilience in downturns — revenue declines but profit remains positive — strongly suggests a substantial recurring component.
Benefit: Recurring aftermarket revenue smooths cyclicality, funds R&D through downturns, and generates returns on the initial capital investment for decades.
Tradeoff: Building the installed base requires patience — the payoff comes years after the initial sale. Companies that optimise for near-term revenue will never build the kind of installed base that Renishaw has.
Tactic for operators: Design your product with aftermarket revenue in mind from the beginning. The consumable, the calibration, the software update — these are not afterthoughts. They are the business model. Price the initial sale to maximise installed base growth, even if it means lower upfront margins.
Principle 9
Treat the balance sheet as a weapon, not a scorecard.
Renishaw has carried net cash on its balance sheet for virtually its entire public history. As of June 2024, net cash stood at approximately £87 million. The company has no material debt, no convertible notes, no financial engineering. The balance sheet is deliberately simple, deliberately strong, and deliberately boring.
This conservatism is not passive — it is an active strategic choice that enables everything else. The net cash position funds counter-cyclical R&D investment. It eliminates the need to raise capital (and accept external governance constraints) during downturns. It provides the optionality to make acquisitions (the MTT Technologies acquisition was done with cash) without the leverage risk that amplifies cyclical earnings. And it signals to customers that Renishaw will still be here in twenty years — a non-trivial consideration for OEMs who design Renishaw components into machines with multi-decade lifespans.
Benefit: Balance sheet strength enables strategic patience, counter-cyclical investment, and customer confidence.
Tradeoff: Returns on equity are lower than they would be with moderate leverage. Capital-efficient investors will always find Renishaw's balance sheet under-optimised. The company returns capital through dividends (yield typically 1.5–2.5%) rather than buybacks, which is less tax-efficient for many shareholders.
Tactic for operators: If your business is cyclical and your competitive advantage compounds with time, carry more cash than your CFO thinks you need. The cost of excess cash (foregone returns) is far lower than the cost of being forced to cut R&D or raise dilutive capital during a downturn.
Principle 10
Plan succession as if the company's culture is the asset.
Renishaw's aborted 2021 sale process and subsequent appointment of Will Lee as CEO represent a succession plan that prioritises cultural continuity over financial optimisation. McMurtry and Deer could have sold to private equity at a substantial premium to the public market price — and chose not to, because the buyer's incentive structure would have destroyed the R&D investment culture that defines the company.
The lesson is that for founder-led companies where culture is the primary competitive advantage, succession planning is not primarily an HR exercise — it is a strategic exercise that must answer the question: what governance structure will preserve the behaviours (counter-cyclical investment, long-term R&D bets, tolerance for ambiguity) that created the advantage?
Benefit: By choosing an internal successor and declining to sell, Renishaw preserved its R&D culture, its UK manufacturing base, and its long-term investment horizon.
Tradeoff: Minority shareholders were denied a premium exit. The declining founder shareholding over coming years will test whether the culture can survive without the governance protection of a controlling stake. The answer is genuinely uncertain.
Tactic for operators: If you are a founder planning succession, ask not "who is the best manager?" but "what governance structure will protect the specific behaviours that created this company's advantage?" The answer might be a management buyout, a trust structure, a dual-class share, or a carefully chosen strategic acquirer — but it is almost never "let the market decide."
Conclusion
The Precision Compounder
The ten principles above resolve into a single meta-principle: Renishaw has built its competitive position by consistently choosing durability over optimisation. UK manufacturing over Asian outsourcing. Counter-cyclical R&D over margin management. Net cash over leveraged returns. Founder patience over quarterly consensus. Interface ownership over platform scale.
Every one of these choices costs something measurable — lower margins, lower returns on equity, more volatile earnings, slower growth in some periods. But the cumulative effect, over five decades, is a company that occupies positions of extraordinary strength in markets that are structurally growing — semiconductor manufacturing, automation, precision medicine, aerospace — with a technology moat that deepens with each R&D cycle and an installed base that generates recurring revenue for decades after the initial sale.
The operating lesson for founders is not to copy Renishaw's specific choices — most companies cannot sustain 15% R&D intensity, most founders do not have 53% ownership stakes, most businesses do not sell products with 30-year replacement cycles. The lesson is to identify the specific form of patience that your competitive advantage requires, and then build the governance and financial structures that protect that patience from the relentless short-term optimisation pressures of public markets, boards, and investors.
Part IIIBusiness Breakdown
The Business at a Glance
Current Vital Signs
Renishaw FY2024
£688.6MRevenue (FY ending June 2024)
£130.5MAdjusted operating profit
19.0%Adjusted operating margin
~£87MNet cash position
5,265Global employees
~£5.1BMarket capitalisation
95%Revenue from outside UK
~15%R&D as % of revenue (5-year avg)
Renishaw is a mid-cap UK industrial technology company that punches dramatically above its weight in strategic importance. With fewer employees than a single Amazon warehouse and revenue roughly equivalent to a mid-sized law firm, it occupies critical-path positions in semiconductor manufacturing, aerospace quality assurance, automotive production, and precision medical devices. The company trades on the London Stock Exchange (RSW.L) and is a constituent of the FTSE 250 index, though its market capitalisation occasionally flirts with the FTSE 100 threshold during upcycles.
The current strategic position is one of cyclical softness layered over secular strength. Revenue in the near term is being suppressed by the semiconductor inventory correction that began in late 2022, reduced Chinese industrial demand, and cautious capex spending across European manufacturing. These headwinds are cyclical. The secular drivers — semiconductor capacity expansion, industrial automation, reshoring of precision manufacturing, digital dentistry adoption, and the AI-driven increase in data centre infrastructure — are intact and accelerating.
How Renishaw Makes Money
Renishaw reports revenue across five product lines, though the operational and strategic distinctions between them are sometimes blurry due to shared technologies and cross-selling.
FY2024 estimated breakdown
| Product Line | Approx. Revenue | % of Total | Growth Outlook |
|---|
| Metrology (CMM & machine tool probes) | ~£400M | ~58% | Stable / Growing |
| Position encoders | ~£140M | ~20% | High growth |
| Additive manufacturing | ~£70M | ~10% | High growth |
Metrology remains the core. CMM probe heads (PH20, REVO) and machine tool probes (OMP, RMP series) are sold to OEM machine builders and directly to end-user factories. Revenue is a mix of initial hardware sales, replacement styli and accessories, calibration services, and software licences. The pricing model is premium — Renishaw's probes cost 20–50% more than lower-end competitors — justified by superior accuracy, reliability, and the depth of the installed base ecosystem.
Position encoders are the fastest-growing segment. Renishaw sells optical and magnetic encoder systems to semiconductor equipment makers, robotics OEMs, and precision motion system integrators. The RESOLUTE absolute encoder family is the flagship, with resolution to 1 nanometre. Revenue is highly geared to semiconductor capex cycles — when ASML ships more lithography machines, encoder revenue surges. The business model is primarily OEM design-in, meaning Renishaw's encoders are specified into customer products at the design stage, creating multi-year revenue visibility (and high switching costs) once a design-in is won.
Additive manufacturing includes sales of RenAM metal laser melting systems, associated consumables (metal powders, build plates), and application engineering services. The dental segment is the most developed vertical, with growing adoption of digital frameworks replacing lost-wax casting. Revenue is growing but the business remains subscale relative to dedicated additive manufacturing companies like EOS or Trumpf.
Spectroscopy is the Raman spectroscopy business — instruments used in pharmaceutical quality control, materials characterisation, and academic research. The inVia confocal Raman microscope is the flagship product. This is a niche, high-margin business with limited growth potential but attractive unit economics.
Medical devices include the neuromate stereotactic robot, neuroinspire surgical planning software, and related neurosurgical instruments. Revenue is small but growing, driven by increasing adoption of robot-assisted stereotactic procedures globally.
The unit economics across the portfolio share a common structure: high gross margins (50–55% at the group level), significant R&D reinvestment (13–18% of revenue), and operating margins that fluctuate between 10% and 25% depending on revenue volume and product mix. The operating leverage is meaningful — Renishaw's cost base is largely fixed (engineering salaries, factory overhead, depreciation), so incremental revenue drops through to profit at high rates.
Competitive Position and Moat
Renishaw's competitive position varies dramatically by product line. In CMM probing, the company holds an estimated 80%+ global market share — a dominance so complete that it is rarely contested in the core product. In machine tool probing, the share is lower (perhaps 50–60%) due to competition from Hexagon (which owns a competing probe business through its acquisition of m&h Inprocess Messtechnik) and Blum-Novotest. In encoders, Renishaw competes against Heidenhain (the German market leader in certain encoder segments), MicroE (now part of Celera Motion / Novanta), and Magnescale (a Sony spin-off). In additive manufacturing, the competitive landscape includes EOS, Trumpf, SLM Solutions (Nikon), Velo3D, and others.
Sources of durable competitive advantage
| Moat Source | Strength | Evidence |
|---|
| Installed base switching costs | Very strong | Millions of probes installed globally; recalibration cost prohibitive |
| OEM design-in lock-in (encoders) | Very strong | Multi-year design cycles; qualification cost deters switching |
| Patent portfolio | Strong | ~4,800 patents/applications; 50-year litigation history |
| Manufacturing process know-how |
The moat is strongest in the core probe business, where fifty years of installed base, OEM integration, and accumulated expertise create switching costs that approach permanence. It is weakest in additive manufacturing, where Renishaw is a subscale player competing against larger, better-funded rivals in a market where the technology is still evolving rapidly and no standard has emerged.
An honest assessment of moat erosion risks:
-
Hexagon is the most formidable competitor. With €5+ billion in revenue across metrology, manufacturing intelligence, and geospatial solutions, Hexagon has the scale and breadth to offer integrated solutions that Renishaw cannot match. Hexagon's acquisition strategy — it has bought hundreds of companies — allows it to bundle hardware, software, and services in ways that could gradually commoditise standalone probe and encoder sales.
-
Keyence is a Japanese sensor and measurement company with ¥960 billion (~£5.2 billion) in revenue, operating margins above 50%, and an aggressive direct-sales model. Keyence does not compete directly in Renishaw's core CMM probe market but is expanding into machine tool measurement and in-line inspection, potentially encroaching on Renishaw's adjacent market segments.
-
Chinese competitors are emerging in lower-end probe and encoder segments. Renishaw's premium positioning provides protection at the high end, but if Chinese manufacturers — supported by government industrial policy — achieve acceptable quality at significantly lower price points, the mid-market could erode.
The Flywheel
Renishaw's competitive compounding operates through a reinforcing cycle that is difficult to interrupt once established:
Self-reinforcing competitive dynamics
1. R&D investment → New products. Renishaw invests 13–18% of revenue in R&D, producing a steady stream of next-generation probes, encoders, and measurement systems that offer measurable performance improvements over predecessors and competitors.
2. New products → Design-in wins. Superior performance wins design-ins with OEM machine builders and semiconductor equipment makers, embedding Renishaw's products in customers' platforms for 5–15 year product cycles.
3. Design-in wins → Installed base growth. Each design-in generates years of hardware sales as the OEM ships machines, plus decades of aftermarket revenue from replacement parts and accessories.
4. Installed base growth → Recurring revenue. The growing installed base generates high-margin replacement styli, calibration services, and software licence revenue that is less cyclical than initial hardware sales.
5. Recurring revenue → R&D funding through cycles. The recurring revenue base, combined with net cash on the balance sheet, allows Renishaw to maintain R&D spending during industry downturns when competitors cut investment.
6. Counter-cyclical R&D → Wider technology gap. Continuous R&D through cycles compounds the technology lead, enabling the next generation of products that restart the flywheel at a higher level.
The flywheel's vulnerability is at the top: if R&D productivity declines — if the company's inventive culture erodes, if the best engineers leave, if the problems become less tractable — the entire cycle degrades. The founder transition is therefore not merely a governance question but a flywheel question: the cultural conditions that produce high R&D productivity are precisely the conditions that founder control has protected.
Growth Drivers and Strategic Outlook
Renishaw's medium-term growth (3–7 years) is driven by five identified vectors, each with varying degrees of visibility and risk:
1. Semiconductor capital expenditure. The expansion of leading-edge semiconductor manufacturing capacity — driven by AI demand, government subsidies (CHIPS Act in the US, EU Chips Act), and reshoring — directly benefits Renishaw's encoder business. ASML alone plans to ship 90+ EUV systems in 2025 and increase capacity for High-NA EUV; each machine contains Renishaw encoders. The total addressable market for precision encoders in semiconductor equipment is estimated at $1.5–2.0 billion by 2028, with Renishaw holding a significant share of the high-precision segment.
2. Industrial automation and robotics. The global installed base of industrial robots is expected to grow from approximately 4 million units in 2023 to 6+ million by 2028 (IFR data). Renishaw's encoders and calibration systems are embedded in robots from FANUC, ABB, and KUKA, and the shift toward collaborative robots and precision assembly applications expands the addressable market.
3. Digital dentistry. The transition from analogue dental workflows (impression, casting, manual framework fabrication) to digital workflows (intraoral scanning, CAD design, additive manufacturing) is a multi-decade shift that is still in early innings globally. Renishaw's metal additive manufacturing systems are positioned as the production solution for digital dental frameworks, with growing adoption in China, Europe, and increasingly the Americas. Market estimates for metal additive manufacturing in dental applications range from $1–3 billion by 2030.
4. Electrification and EV manufacturing. The shift to electric vehicles increases demand for precision machining of battery components, electric motor housings, and power electronics — all of which require in-process measurement. Renishaw's machine tool probes and gauging systems are well-positioned for this transition. The complexity and tolerance requirements of EV drivetrains often exceed those of internal combustion engines, expanding the per-vehicle metrology content.
5. Medical devices and neurosurgery. Growing adoption of robot-assisted stereotactic neurosurgery, particularly for epilepsy diagnosis (SEEG procedures) and deep brain stimulation, provides a small but expanding market. Renishaw's neuromate system is one of only two FDA-cleared stereotactic robots (the other being Medtronic's StealthStation), and procedure volumes are growing at double-digit rates in the US and Europe.
Key Risks and Debates
1. Founder succession and governance transition. The single most significant risk. McMurtry's shareholding (approximately 36% as of early 2024, down from 37%+) provides governance protection for the R&D-intensive, long-term investment culture. As the shareholding is reduced through estate planning, the governance protection weakens. If the combined McMurtry-Deer stake falls below 30%, Renishaw becomes vulnerable to activist pressure, hostile takeover approaches, or board-driven strategic shifts toward shorter-term optimisation. Severity: existential to the culture, though the business franchise may persist regardless.
2. China revenue concentration and geopolitical risk. China represents 15–20% of group revenue and is Renishaw's largest single-country market in some years. The combination of rising US-China technology restrictions (which could limit exports of precision metrology and encoder equipment), Chinese government pressure to substitute domestic suppliers, and broader geopolitical risk creates a material revenue threat. A scenario in which China-derived revenue fell by 50% over five years would reduce group revenue by 8–10%. Severity: material and partially mitigated by geographic diversification, but the pace of geopolitical deterioration is unpredictable.
3. Hexagon's platform strategy. Hexagon's acquisition of hundreds of companies across metrology, CAD/CAM, and manufacturing intelligence has created an integrated platform that can offer customers a single-vendor solution spanning design, production, and inspection. If major CMM OEMs (some of which are Hexagon subsidiaries) shift to proprietary probing systems, Renishaw's CMM probe market share — currently 80%+ — could erode. This risk is partially mitigated by Renishaw's superior probe technology and by anti-competitive dynamics (CMM users prefer vendor-neutral probe standards), but it is the most credible competitive threat to the core business over the next decade. Severity: low probability but high impact; worth monitoring quarterly.
4. Semiconductor cycle amplitude. The semiconductor capex cycle is Renishaw's most volatile revenue driver. The 2023–2024 inventory correction reduced encoder orders materially, and recovery timing depends on factors (memory pricing, data centre investment cadence, consumer electronics demand) outside Renishaw's control. A prolonged semiconductor downturn — say, an 18-month correction similar to 2019 — could reduce group revenue by 10–15% and compress operating margins below 15%. Severity: cyclical, not structural, but painful in duration.
5. Currency exposure. Renishaw manufactures predominantly in the UK (cost base largely in sterling) and sells predominantly overseas (revenue in dollars, euros, yen, and renminbi). Sterling strength compresses reported revenue and margins. A 10% appreciation of sterling against the dollar reduces reported revenue by approximately £30–40 million. The company hedges selectively but cannot eliminate structural currency mismatch. Severity: chronic and unavoidable; material in strong-sterling environments.
Why Renishaw Matters
Renishaw matters for reasons that transcend its revenue line or share price.
For operators and founders, it is a masterclass in building a technology business on the principle that durability beats optimisation. McMurtry and Deer chose, at every fork, the path that compounded long-term advantage at the cost of short-term efficiency: UK manufacturing over outsourcing, counter-cyclical R&D over margin management, net cash over leverage, founder control over professional management. The result, five decades later, is a company that occupies the critical measurement layer of the global manufacturing stack — invisible, essential, and nearly impossible to displace.
For investors, Renishaw poses a valuation puzzle that is itself instructive. The stock typically trades at 25–35x earnings — a premium to UK industrial peers but a discount to comparable US precision technology companies (Keyence, for instance, trades at 45–60x). The premium reflects the moat; the discount reflects the cyclicality, the geographic concentration risk, and the governance uncertainty around founder succession. The investment question reduces to: will the culture survive the founders? If yes, Renishaw at 25x through-cycle earnings may be significantly undervalued as secular growth in semiconductors, automation, and precision medicine drives multi-decade revenue expansion. If no — if the R&D spend is cut, the UK manufacturing base rationalised, and the company optimised for near-term returns — then the premium erodes quickly, and Renishaw becomes another well-managed but undifferentiated European industrial.
The deeper lesson is about what compounds. Not revenue. Not margins. Not even technology, exactly. What compounds at Renishaw is precision itself — the accumulated institutional knowledge of how to measure the physical world more accurately than anyone else, encoded in patents, processes, people, and a culture that rewards solving problems at the edge of possibility. McMurtry's spring-loaded probe, clicking against metal in a Gloucestershire factory, is still counting the shape of the world. The question is whether anyone, after McMurtry, will have the patience to let it keep counting.
